In a model of triple-negative breast cancer, Wang et al. reported that metformin influences PD-L1 expression through the JNK signaling pathway, that has regulatory effects on the immune microenvironment [17]. This evidence concerns the gene MAPK8 and triple-negative breast carcinoma.